Anti-CS IgM autoantibody serum level was also lower in both NMOSD and MS suggesting that reduced CD180 expression of NS B cells could contribute to the deficient IgM autoantibody production in these disorders. This evidence concerns the gene CD180 and myeloid sarcoma.